Category Biodiversity/Genetic Resources/Biotech

European Parliament Set To Reprimand Mandelson For Pressuring Thailand

By David Cronin for Intellectual Property Watch BRUSSELS – The European Parliament looks set to take Brussels’ top trade official to task over his latest attempt to persuade Thailand that it should revise its policy on pharmaceutical patents. Shortly after…

Proponents: ‘Time Is Now’ For TRIPS Biodiversity Amendment In Doha Round

By William New India and other proponents on Wednesday sought to counter concern raised by the World Trade Organization chief that a “clash” could occur if differences are not narrowed on a proposed amendment to WTO intellectual property rules for…

WHO IP And Health Group Concludes With Progress; Tough Issues Remain For Assembly

Note: The latest version of the draft strategy (dated Saturday, 3 May, 14.00h) is now available on the WHO website [click here]. By Kaitlin Mara and William New The World Health Organization (WHO) negotiations on public health, intellectual property and…

WHO Members Inch Toward Consensus On IP, Innovation And Public Health

By Kaitlin Mara and William New Members of the World Health Organization (WHO) gathered this week to address innovation and intellectual property issues in public health saw hope for agreement on a strategy paper focused on the needs of developing…

Débat sur les politiques en matière de cartographie des brevets appliqués aux sciences de la vie

Kaitlin Mara Il est aussi important que compliqué d’avoir accès à des données de qualité sur les politiques menées en matière de propriété intellectuelle appliquée aux sciences de la vie. Telle est la conclusion d’une récente réunion d’experts techniques relative…

Los expertos examinan la reglamentación de los estudios de situación de las patentes para las biociencias

Por Kaitlin Mara Tener acceso a datos de calidad en el contexto de la reglamentación de la propiedad intelectual en el ámbito de las biociencias es una cuestión tan necesaria como difícil, según se dijo en una reunión de expertos…

Brazil Declares Patented AIDS Drug Of Public Interest, Could Expand Access

By Claudia Jurberg for Intellectual Property Watch The Brazilian government recently declared the drug Tenofovir, used against HIV/AIDS, to be of public interest. The announcement signals the country’s interest in using an option to avoid the patent on the drug…

Experts Discuss Policy On Patent Landscapes For Life Sciences

By Kaitlin Mara Access to quality data in intellectual property policy in the life sciences is as necessary as it is hard to obtain, said a recent meeting of technical experts, called to discuss challenges in patents and innovation in…

Further Resolution Needed To Keep IP Issues In WTO Negotiations

By Kaitlin Mara Intellectual property rights issues on the table in the newly invigorated World Trade Organization negotiations are at risk if remaining deep differences cannot be further narrowed in the coming weeks, WTO Director General Pascal Lamy said Thursday.…

Innovative Partnership To Create Another Patent-Free Malaria Drug

By Catherine Saez After an innovative partnership between a non-governmental group and a pharmaceutical company led to a new cheap non-patented drug against malaria being available in Africa in 2007, the model is being implemented again with another new non-patented…